In a further sub-group analysis, the six patients with partial membranous expression had a significant shorter median overall (median: 10.9 vs 18.7 months, P=0.03) and tumour recurrence-free survival (median: 6 vs 15 months, P=0.02) compared with tumours with non-membranous ALCAM staining (Figure 3B, Table 3). The gene discussed is ALCAM; the disease is neoplasm.